Similar articles

• NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.

  Jenkins CM, Waterman MR. Jenkins CM, et al. Biochemistry. 1998 Apr 28;37(17):6106-13. doi: 10.1021/bi973076p. Biochemistry. 1998. PMID: 9558349
• Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.

  Dong MS, Yamazaki H, Guo Z, Guengerich FP. Dong MS, et al. Arch Biochem Biophys. 1996 Mar 1;327(1):11-9. doi: 10.1006/abbi.1996.0086. Arch Biochem Biophys. 1996. PMID: 8615680
• Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.

  Gruez A, Pignol D, Zeghouf M, Covès J, Fontecave M, Ferrer JL, Fontecilla-Camps JC. Gruez A, et al. J Mol Biol. 2000 May 26;299(1):199-212. doi: 10.1006/jmbi.2000.3748. J Mol Biol. 2000. PMID: 10860732
• P450BM-3; a tale of two domains--or is it three?

  Peterson JA, Sevrioukova I, Truan G, Graham-Lorence SE. Peterson JA, et al. Steroids. 1997 Jan;62(1):117-23. doi: 10.1016/s0039-128x(96)00169-9. Steroids. 1997. PMID: 9029725 Review.
• Evolution of bioinorganic motifs in P450-containing systems.

  Degtyarenko KN, Kulikova TA. Degtyarenko KN, et al. Biochem Soc Trans. 2001 May;29(Pt 2):139-47. doi: 10.1042/0300-5127:0290139. Biochem Soc Trans. 2001. PMID: 11356142 Review.